Skip to main content
. 2022 May 23;10:857436. doi: 10.3389/fped.2022.857436

Figure 1.

Figure 1

(A) Treatment approach for patients with kaposiform hemangioendothelioma. KHE, kaposiform hemangioendothelioma; KMP, Kasabach-Merritt phenomenon; SIR, sirolimus; VCR, vincristine. (B) Treatment approach for patients with complicated vascular malformations. *Steady state is defined as a stable disease in two consecutive MRT volumetries at least 6 months apart.